Hancock Jaffe Laboratories Inc (HJLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HJLI | ALDX | PYPD | ||
| Company | Hancock Jaffe Laboratories Inc | Aldeyra Therapeu | Polypid Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.71 | 1.5500 | 4.55 | ||
| High | 10.75 | 1.5900 | 4.60 | ||
| Low | 10.26 | 1.4700 | 4.28 | ||
| Latest | 10.38 | 1.5000 | 4.53 | ||
| Change | -0.21 | -0.0700 | +0.10 | ||
| % Change | -1.98% | -4.46% | +2.26% | ||
| Volume | 221,800 | 706,200 | 41,500 | ||
| 20-Day Average Volume | 295,705 | 1,667,245 | 54,075 | ||
| Previous Close | 10.59 | 1.5700 | 4.43 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.16 | 1.6660 | 4.49 | ||
| 20-Day Raw Stochastic | 73.54% | 7.14% | 64.47% | ||
| 20-Day Relative Strength | 67.86 | 31.73 | 52.44 | ||
| Weighted Alpha | +9.05 | -31.62 | +57.30 | ||
| Today's Opinion | 88% Buy | 100% Sell | 88% Buy | ||
| Previous Opinion | 88% Buy | 100% Sell | 80% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.34% since 09/23/21 | -11.76% since 04/22/26 | -3.82% since 04/22/26 | ||
| Low | 9.49 on 09/24/21 | 1.4700 on 04/29/26 | 4.28 on 04/29/26 | ||
| High | 11.38 on 09/29/21 | 1.7000 on 04/23/26 | 4.80 on 04/23/26 | ||
| 1-Month | |||||
| %Chg | +34.98% since 08/30/21 | -15.25% since 03/27/26 | +5.84% since 03/27/26 | ||
| Low | 7.60 on 09/07/21 | 1.4700 on 04/29/26 | 4.04 on 04/08/26 | ||
| High | 11.38 on 09/29/21 | 1.8900 on 04/14/26 | 4.80 on 04/23/26 | ||
| 3-Month | |||||
| %Chg | +51.09% since 06/30/21 | -71.80% since 01/29/26 | -3.82% since 01/29/26 | ||
| Low | 5.36 on 07/19/21 | 1.0700 on 03/17/26 | 4.01 on 03/02/26 | ||
| High | 11.38 on 09/29/21 | 5.9300 on 01/30/26 | 5.12 on 02/03/26 | ||
| 6-Month | |||||
| %Chg | +62.70% since 03/30/21 | -70.33% since 10/29/25 | +19.21% since 10/29/25 | ||
| Low | 4.99 on 05/13/21 | 1.0700 on 03/17/26 | 3.50 on 11/21/25 | ||
| High | 11.38 on 09/29/21 | 5.9300 on 01/30/26 | 5.12 on 02/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 90,146 | 94,487 | 84,538 | ||
| Shares Outstanding, K | 8,685 | 60,183 | 19,083 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -9,140,000 | -33,850,000 | -34,170,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -2,380,000 | -6,460,000 | -8,470,000 | ||
| 60-Month Beta | 1.51 | 1.34 | 1.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.11 on 02/27/26 | -0.41 on 02/11/26 | ||
| Earnings Date | 11/16/21 | 05/13/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||